CONFERENCES:
- An Cheng,Lixuan Tan, Aparna Lakkaraju. RPE mitochondrial deficits and complement C3a
receptor activation drive retinal degeneration in frontotemporal dementia. ARVO 2024 Annual Meeting (2024. 5.4-9) (BOO33,Poster, Seatle, USA) - An Cheng, Kohji Fukunaga. Epsin2 regulates alpha-synuclein propagation via FABP7 in multiple system atrophy. The 46th Annual Meeting of the Japan Neuroscience Society (2023. 8.1-4) (C001015, Symposium, Invited Speaker, Sendai, Japan)
- An Cheng, Pathophysiological significance of glial FABP7 in multiple system atrophy, Protein misfolding disease and therapy 2022 (Tohoku University, online), March 5, 2022。
- An Cheng, Takuya Sasaki, Kohji Fukunaga. Novel therapeutic ligand ameliorates oligodendrocyte injury in multiple sclerosis mouse models via fatty acid-binding protein 5 and 7 inhibition. International Graduate Student Conference in Pharmaceutical Sciences (2021.11.26-27) (Poster, in China) (The Best Poster Award).
- An Cheng, Kohji Fukunaga. Pathophysiological significance of glial FABP7 in the synucleinopathies. The 47th Annual Meeting of the Japan Brain Science Society (2020.11.21-22) (Poster, in Japan) (Outstanding Poster Presentation Awards).
- An Cheng, Shinoda, Y, Matsuo, K, Fukunaga. FABP3 ligands inhibiting alpha-synuclein oligomerization in Neuro2A cells. 29th International Symposium on Cerebral Blood Flow, Metabolism and Function / 14th International Conference on Quantification of Brain Function with PET (BRAIN and BRAIN Pet) (2019.7.04-07) (Oral, in Japan).
- An Cheng, Yasuharu Shinoda, Tetsunori Yamamoto, Kohji Fukunaga. Development of FABP3 ligands inhibiting α-synuclein oligomerization induced by arachidonic acid. The 92nd Annual Meeting of the Japanese Pharmacological Society (2019.3.14-16) (Oral, in Japan).
- An Cheng, Yasuharu Shinoda, Tetsunori Yamamoto, Kohji Fukunaga. Development of FABP3 ligands inhibiting α-synuclein oligomerization induced by arachidonic acid. The 69th North Branch Meeting of the Japanese Pharmacological Society. (2018.9.21) (Oral, in Japan).
- An Cheng, Yasuharu Shinoda, Tetsunori Yamamoto, Kohji Fukunaga. Development of FABP3 ligands inhibiting α-synuclein oligomerization induced by arachidonic acid. The 57th Northeast Branch Meeting of the Pharmaceutical Society of Japan (2018.10.20) (Oral, in Japan).
- An Cheng,Lixuan Tan, Aparna Lakkaraju. RPE mitochondrial deficits and complement C3a
An Cheng`s Homepage
Website
https://user-assets.sxlcdn.com/images/858011/FhMq96kK0tK5X-2RuuFA_1uBUUyV.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/quality/90!/format/png